Arbor Rapha Capital Bioholdings I (ARCK) has a debt-to-equity ratio of -0.0, below the sector sector average of 0.2.
Get informed when a big investor buys or sells
+ Follow0.00
Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.
The latest debt-to-equity ratio for ARCK is -0.0. That is below the sector sector average of 0.2. Investors often review this figure alongside Arbor Rapha Capital Bioholdings I's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, ARCK currently prints -0.0 for debt-to-equity ratio, while the sector average sits near 0.2. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Arbor Rapha Capital Bioholdings I's growth, margins, and balance sheet.
A debt-to-equity ratio of -0.0 for Arbor Rapha Capital Bioholdings I is not 'good' or 'bad' on its own. Compare it with the peer average (0.2) and with ARCK's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting ARCK's debt-to-equity ratio (-0.0), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.